Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

The classification of HIV/Aids and TB in the pandemics category, rather than chronic diseases, has made thousands of patients pay out-of-pocket for services that should be covered under the national ...

Encourage children to love science by showing them the world in miniature with some of the best microscopes for kids — here are our favorite models. The best microscopes for kids allow children ...

The Motorola ‘Edge’ series of smartphones are some of the lightest and most feature-packed mid-range phones available on the market. Last year, Motorola created waves across the tech community ...

After a lifetime on the frontiers of the fight against HIV, Linda-Gail Bekker could finally ... Because ultimately, if we can bring this epidemic under control more quickly, it’s going to ...

Lenacapavir was granted breakthrough therapy designation for HIV prevention by the FDA in October 2024 and will be reviewed by the FDA under priority review, with an assigned Prescription Drug ...

Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and tuberculosis ... time the orphanage came under scrutiny over allegations ...

“California’s high-speed rail is 171 miles under active construction, with over 50 major structures completed, 14,700 jobs created, and more than 880 small businesses engaged. This investment ...